Cargando…
Comparative Human Factors Evaluation of Two Nasal Naloxone Administration Devices: NARCAN(®) Nasal Spray and Naloxone Prefilled Syringe with Nasal Atomizer
INTRODUCTION: Opioid overdose rescue situations are time-critical, high-stress scenarios that frequently require nonmedical first responders or bystanders to intervene and administer naloxone to avoid opioid-induced fatalities. Training nonmedical personnel to respond during such mentally constraini...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513948/ https://www.ncbi.nlm.nih.gov/pubmed/30877583 http://dx.doi.org/10.1007/s40122-019-0118-0 |
Sumario: | INTRODUCTION: Opioid overdose rescue situations are time-critical, high-stress scenarios that frequently require nonmedical first responders or bystanders to intervene and administer naloxone to avoid opioid-induced fatalities. Training nonmedical personnel to respond during such mentally constraining situations presents the human factors challenge of how best to design a safe and effective lay delivery system. This paper comparatively evaluates the ease of use of two nasal naloxone administration products: NARCAN(®) Nasal Spray and a naloxone prefilled syringe with nasal atomizer (PFS-NA). METHODS: We evaluated the use requirements and usability of NARCAN(®) Nasal Spray versus a naloxone PFS-NA using a systems-oriented method. First, we determined the use requirements of different user groups. Next, we focused on constructing a human factors task analysis of both products. Finally, we conducted a comparative risk assessment of the tasks that were different between the two products. RESULTS: Inexperienced users, such as nonmedical first responders and bystanders, are at the highest risk of incorrectly administering naloxone, particularly in high-stress emergency opioid overdose situations. The device Preparation and Medication Delivery tasks most differentiate the use of NARCAN(®) Nasal Spray and a PFS-NA. The level of task complexity and number of steps within those tasks is substantially greater for a PFS-NA than for the NARCAN(®) Nasal Spray. CONCLUSIONS: NARCAN(®) Nasal Spray requires fewer steps and is easier to administer than a naloxone PFS-NA. Thus, using NARCAN(®) Nasal Spray should increase the likelihood that nonmedical personnel correctly deliver naloxone in time-critical, high-stress opioid overdose rescue situations. FUNDING: ADAPT Pharma, Inc. |
---|